(Q34047372)

English

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

1 reference

Europe PubMed Central

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C Mascaux

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M Paesmans

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

T Berghmans

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

F Branle

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J J Lafitte

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

F Lemaitre

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A P Meert

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

P Vermylen

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J P Sculier

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

European Lung Cancer Working Party (ELCWP)

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

23-36

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Small cell lung cancer. State-of-the-art therapy 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance chemotherapy for small cell lung cancer: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and meta-analysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy in small cell lung carcinoma: A randomized study of two intensive regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of long-term survival in extensive small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating chemotherapy with or without VP-16 in extensive-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vincristine, doxorubicin and cyclophosphamide with and without etoposide in limited small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide versus methotrexate in small cell bronchial carcinoma. A randomized study of two types of four-drug chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing cyclophosphamide, doxorubicin, vincristine (CAV) with cyclophosphamide, etoposide, vincristine, methotrexate (CEVM) in patients with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomised study in limited disease small cell carcinoma--doxorubicin and vincristine plus either cyclophosphamide or etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Does the substitution of cisplatin in a standard four drug regimen improve survival in small cell carcinoma of the lung? A comparison of two chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Swiss Group for Clinical Cancer Research (SAKK)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(00)00127-6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34047372&oldid=1993785208"